INVA
NASDAQ HealthcareInnoviva, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $21.97 |
|---|---|
| Volume | 585,352 |
| Market Cap | 1.64B |
| Beta | 0.420 |
| RSI (14-Day) | 35.1 |
| 200-Day MA | $20.09 |
| 50-Day MA | $21.28 |
| 52-Week High | $25.15 |
| 52-Week Low | $16.52 |
| P/E Ratio | 6.66 |
| Forward P/E | 9.94 |
| Price / Book | 1.40 |
🎯 Investment Strategy Scores
How INVA scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
46/100
High dividend yield + low volatility
🚀 Moon Shot
27/100
High growth potential (high beta + oversold)
🔪 Falling Knife
41/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
43/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
35/100
Large-cap, institutional-quality stocks
Find INVA in your text
Paste any text on the homepage — the tool will extract INVA and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.